FundedIQ
Biotechnology

Alzprotect: Funding, Investors & Team (Oct 2026)

AlzProtect is a biopharmaceutical organization creating drug competitors from disclosure to clinical preliminaries for the treatment of neurodegenerative illnesses including Alzheimer's sickness (AD) and vagrant tauopathies like Progressive Supranuclear Palsy (PSP).

www.alzprotect.com Street, United States 1-10 employees
Biotechnology Clinical Trials Medical Pharmaceutical
Total raised
$340k
Rounds
1
Latest
Grant
Jun 2022

Alzprotect has raised $340k across 1 funding round on record, the most recent a Grant of $340k announced in Jun 2022.

That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Alzprotect Company Profile and Key Stats

Total funding raised
$340k
across 1 round on record
Funding rounds on record
1
Latest funding round
Grant
$340k in Jun 2022
Employees
1-10
reported band
Headquarters
Street, United States

Latest funding round on record: Jun 2022.

Alzprotect Funding Rounds

Date
Round
Amount
Grant
$340k

Alzprotect Founders and Leadership Team

Name
Role
Contact
Patricia Melnyk
Founder
—

No contact details are on record for this team yet.

Alzprotect Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M
1,065
—

Alzprotect's latest round of $340k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Alzprotect in Biotechnology and Street

Companies Similar to Alzprotect

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Alzprotect Funding FAQs

What does Alzprotect do?

AlzProtect is a biopharmaceutical organization creating drug competitors from disclosure to clinical preliminaries for the treatment of neurodegenerative illnesses including Alzheimer's sickness (AD) and vagrant tauopathies like Progressive Supranuclear Palsy (PSP).

How much funding has Alzprotect raised?

Alzprotect has raised $340k across 1 round on record. The most recent is a Grant of $340k announced in Jun 2022.

When did Alzprotect last raise funding?

Alzprotect's most recent funding round on record is a Grant of $340k, announced in Jun 2022.

Who founded Alzprotect?

FundedIQ lists Patricia Melnyk (Founder) at Alzprotect.

Where is Alzprotect headquartered?

Alzprotect is based in Street, Maryland, United States.

How many employees does Alzprotect have?

Alzprotect is in the 1-10 employee band.

How does Alzprotect's funding compare to other Biotechnology startups?

Alzprotect's latest round of $340k is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Alzprotect Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Alzprotect is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.